Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New Future Leaders Fellow Dr Beccano-Kelly will lead research into synaptic health over time in neurodegeneration. Watch our video interview with Dayne to find out more about his career to date, successful application and future plans.

Oxford Parkinson's Disease Centre Career Development Fellow in Neurobiology Dr Dayne Beccano-Kelly has been awarded a Future Leaders Fellowship by UK Research and Innovation to start a laboratory at Cardiff University. The UKRI's flagship scheme is designed to establish the careers of world-class research and innovation leaders across the UK. Significant government investment is awarded to enable top class researchers to tackle the major research challenges and drive forward transformative new ideas.

As part of his OPDC Fellowship, Dr Beccano-Kelly designed his project to look at electrophysiological dysfunction in human induced pluripotent Stem cell (iPSC) models of disease and related molecular mechanisms such as calcium homeostasis. Dr Beccano-Kelly said: "This work contributed to my burgeoning belief of the temporal nature of neurodegeneration. Specifically, that signs and symptoms start early and contribute to the late stage neurodegeneration observed."

Director of the Oxford Parkinson's Disease Centre Professor Richard Wade-Martins said: "I am very pleased that Dayne has been awarded a UKRI Future Leaders Fellowship to establish his own laboratory at Cardiff. For the last five years Dayne has held a Career Development Fellowship at the Oxford Parkinson’s Disease Centre and I am delighted that this support has enabled him to make the move to independence. Training and investing in the next generation of researchers is so important to further build strength and capacity in neuroscience in the UK and I have no doubt Dayne will be extremely successful."

From early 2021, Dr Beccano-Kelly's new lab will work on synaptic health over time in neurodegeneration to identify dysfunctional mechanisms and early stage modifiable therapeutic targets. According to Dr Beccano-Kelly: "Identifying such targets will allow for the development of treatments that would halt the progression of the disease before the late stage debilitating and devastating symptoms ever manifest!"

Dr Beccano-Kelly has an important message for postdoctoral fellows looking to take the next step in their career towards independent research: "Collaboration is critical to moving the science and yourselves forwards. Seek it out everywhere you go, never turn your nose up at it but embrace it and see how to make it work!"

Read more about the Fellowship in the UK Research and Innovation website article "UKRI invests £109 million in future leaders".

Similar stories

Oxford Parkinson’s Disease Centre host the 2022 Oxford Parkinson’s Research Day

On Tuesday 29th November 2022, Professor Richard Wade-Martins and Professor Michele Hu from the Oxford Parkinson’s Disease Centre (OPDC) hosted the Oxford Parkinson’s Research Day at the Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford.

Strong performance for DPAG cardiac research at the Oxford BHF CRE Annual Symposium

Congratulations are in order for Kaitlyn Dennis, Dr Ni Li and Dr KC Park on their awards at this year's major showcase for Oxford's British Heart Foundation funded researchers.

Jaideep Pandit honoured with RCoA Gold Medal

Congratulations are in order for Professor Jaideep Pandit, Professor of Anaesthesia and consultant anaesthetist, who has received the rarely awarded prestigious Gold Medal of the Royal College of Anaesthetists. Professor Pandit was a student and research fellow at DPAG and is now an Academic Visitor in the department; he is also a Fellow and Tutor in Medicine at St John's College.

Louisa Zolkiewski awarded the Bruce Cattanach Prize 2022

Congratulations are in order for Louisa Zolkiewski, who completed her DPhil studies this year, on being awarded the 2022 Bruce Cattanach Prize by the Genetics Society for her DPhil thesis.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.